Will I have to put up any money to get started?

Our initial consultation is always free. Most cases use a contingent fee contract, meaning we do not get paid until or unless our clients make a recovery. This contingent fee will be a percent of the recovery, calculated before deducting expenses. In some circumstances, a retainer agreement may include representation on an hourly basis. However, we recommend speaking with an attorney to learn more.

What do you need to know about my potential case?

When someone from our law firm speaks with you, we'll need to gather some basic information about your case. This can include names and dates, as well as a timeline relating to the claim. The more information you can provide, the better.

Where does Motley Rice handle cases?

Motley Rice represents clients across the globe. We litigate cases in all 50 states, as well as internationally. We are comfortable working along with co-counsel if needed.

What can I do if I'm not sure that I'm completing the right form?

We understand that it may feel overwhelming trying to get all of the details right. If you're unsure that you're completing the right form, please call 1.800.768.4026. Our staff can work with you to understand your claim and do what we can to help.

Clinical Trial Complications: Pharmacia Corp

This case is no longer active

The Legal Team

Gregg S. Levin

Meghan S. B. Oliver

View Other Attorneys

Securities Attorneys

Case Overview

When companies misrepresent critical information that affects shareholder value, investors and stakeholders can play a valuable role by litigating to help hold the companies accountable and to recover lost investment funds.

Alaska Electrical Pension Fund v. Pharmacia Corp.

In Feb. 2013, the U.S. District Court for the District of New Jersey granted final approval of a $164 million settlement for investors who purchased common stock of Pharmacia Corporation between April 17, 2000, and August 5, 2001.

Motley Rice served as co-class counsel in this federal securities fraud litigation alleging that the defendants, including Pharmacia Corporation, Pfizer Inc. and numerous former executives, misrepresented the results of a 2000 clinical trial involving the gastrointestinal benefits of Celebrex® to make its safety profile appear better than rival drugs. These allegedly misleading statements led to shareholders’ alleged loss of billions.

We applaud our client, PACE Industry Union Industry Management Pension Fund, and the other five class representatives that stepped forward to pursue this important litigation.

Alaska Electrical Pension Fund v. Pharmacia Corp., Consol. No. 03-1519 (AET) (D.N.J.)

Documents:

Final Judgment and Order of Dismissal with Prejudice (U.S. District Court of New Jersey, Jan. 30, 2013)

If you have questions regarding cases similar to the Alaska Electrical Pension Fund v. Pharmacia Corp settlement or if you would like to discuss a potential case, contact our securities team by email or call 1.800.768.4026.

*Prior results do not guarantee a similar outcome.